Mark B. Evers
Impact in
-
- Phytochemicals and Medicinal Plants
- Cancer Research top 10%
- Cancer, Lipids, and Metabolism
- Cancer, Hypoxia, and Metabolism
Papers in
- Oncology 13
- Lung Cancer Research Studies 8
- Colorectal Cancer Treatments and Studies 3
- Epidemiology 10
- Neuroendocrine Tumor Research Advances 9
- Co-authors
- Chendil Damodaran (1 shared paper)Srinivas V. Koduru (1 shared paper)Raj Kumar (1 shared paper)Sowmyalakshmi Srinivasan (1 shared paper)Piotr Rychahou (7 shared papers)Heidi L. Weiss (4 shared papers)Hung Q. Doan (1 shared paper)Robert Paul Thomas (1 shared paper)
- Journals
- Journal of the American College of Surgeons (12 papers)Journal of Clinical Oncology (6 papers)Oncotarget (4 papers)Molecular Cancer Therapeutics (1 paper)Diseases of the Colon & Rectum (1 paper)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Mark B. Evers
26 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 100
- Complementary and alternative medicine 133
- Cancer Research 176
- Oncology 250
- Endocrinology, Diabetes and Metabolism 136
- Epidemiology 149
Countries citing papers authored by Mark B. Evers
This map shows the geographic impact of Mark B. Evers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark B. Evers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark B. Evers more than expected).
Fields of papers citing papers by Mark B. Evers
This network shows the impact of papers produced by Mark B. Evers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark B. Evers. The network helps show where Mark B. Evers may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark B. Evers, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 209 | |
| 2 | 2010 | 191 | |
| 3 | 2007 | 183 | |
| 4 | 2010 | 119 | |
| 5 | 2018 | 102 | |
| 6 | 2002 | 87 | |
| 7 | 1988 | 59 | |
| 8 | 2019 | 52 | |
| 9 | 2018 | 42 | |
| 10 | 2017 | 27 | |
| 11 | 2018 | 22 | |
| 12 | 2015 | 20 | |
| 13 | 2003 | 13 | |
| 14 | 2020 | 9 | |
| 15 | 2021 | 9 | |
| 16 | 2019 | 4 | |
| 17 | 2020 | 4 | |
| 18 | 2004 | 2 | |
| 19 | 2019 | 1 | |
| 20 | 2023 | 1 |
About Mark B. Evers
Mark B. Evers is a scholar working on Oncology, Epidemiology, Molecular Biology, Neurology and Surgery, having authored 27 papers that have together received 1.2k indexed citations. Recurring topics across this work include Neuroendocrine Tumor Research Advances (9 papers), Lung Cancer Research Studies (8 papers), Neuroblastoma Research and Treatments (6 papers), Colorectal Cancer Treatments and Studies (3 papers), Cancer, Lipids, and Metabolism (2 papers), Cancer therapeutics and mechanisms (2 papers), Genetic factors in colorectal cancer (2 papers) and PI3K/AKT/mTOR signaling in cancer (2 papers). The work is most often cited by research in Complementary and alternative medicine (133 citations), Cancer Research (176 citations), Oncology (250 citations), Endocrinology, Diabetes and Metabolism (136 citations) and Epidemiology (149 citations). Mark B. Evers has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Chendil Damodaran, Srinivas V. Koduru, Raj Kumar, Sowmyalakshmi Srinivasan, Piotr Rychahou, Heidi L. Weiss, Hung Q. Doan, Robert Paul Thomas, Lindsey N. Jackson and Taylor S. Riall. Their work appears in journals such as Journal of the American College of Surgeons, Journal of Clinical Oncology, Oncotarget, Molecular Cancer Therapeutics and Diseases of the Colon & Rectum.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.